Lexchin J - Search Results

1

One step forward, one step sideways? Expanding research capacity for neglected diseases.

Lexchin J. Lexchin J. BMC Int Health Hum Rights. 2010 Jul 14;10:20. doi: 10.1186/1472-698X-10-20. BMC Int Health Hum Rights. 2010. PMID: 20630063 Free PMC article.

2

Canada's patented medicine notice of compliance regulations: balancing the scales or tipping them?

Lexchin J. Lexchin J. BMC Health Serv Res. 2011 Mar 24;11:64. doi: 10.1186/1472-6963-11-64. BMC Health Serv Res. 2011. PMID: 21435247 Free PMC article.

3

Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews.

Bishop D, Lexchin J. Bishop D, et al. Among authors: lexchin j. BMC Health Serv Res. 2013 Mar 9;13:88. doi: 10.1186/1472-6963-13-88. BMC Health Serv Res. 2013. PMID: 23497271 Free PMC article.

4

Why are there deadly drugs?

Lexchin J. Lexchin J. BMC Med. 2015 Feb 5;13:27. doi: 10.1186/s12916-015-0270-2. BMC Med. 2015. PMID: 25656293 Free PMC article.

5

Relationship between pharmaceutical company user fees and drug approvals in Canada and Australia: a hypothesis-generating study.

Lexchin J. Lexchin J. Ann Pharmacother. 2006 Dec;40(12):2216-22. doi: 10.1345/aph.1H117. Epub 2006 Nov 28. Ann Pharmacother. 2006. PMID: 17132811

6

Clinical trials in Canada: whose interests are paramount?

Lexchin J. Lexchin J. Int J Health Serv. 2008;38(3):525-42. doi: 10.2190/HS.38.3.h. Int J Health Serv. 2008. PMID: 18724580

7

Coverage with evidence development for pharmaceuticals: a policy in evolution?

Lexchin J. Lexchin J. Int J Health Serv. 2011;41(2):337-54. doi: 10.2190/HS.41.2.h. Int J Health Serv. 2011. PMID: 21563627

8

The danger of imperfect regulation: OxyContin use in the United States and Canada.

Lexchin J, Kohler JC. Lexchin J, et al. Int J Risk Saf Med. 2011;23(4):233-40. doi: 10.3233/JRS-2011-0539. Int J Risk Saf Med. 2011. PMID: 22156088

9

International comparison of assessments of pharmaceutical innovation.

Lexchin J. Lexchin J. Health Policy. 2012 May;105(2-3):221-5. doi: 10.1016/j.healthpol.2012.02.005. Epub 2012 Mar 8. Health Policy. 2012. PMID: 22405485

10

Models for financing the regulation of pharmaceutical promotion.

Lexchin J. Lexchin J. Global Health. 2012 Jul 11;8:24. doi: 10.1186/1744-8603-8-24. Global Health. 2012. PMID: 22784944 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page